PETERSBURG, Va.--(BUSINESS WIRE)--Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.

弗吉尼亚州彼得堡-（商业线）-Civica Inc.（Civica，Civica Rx）很自豪地宣布制药行业领导者Bouwien Smits已加入Civica，成为该公司新无菌注射的新现场副总裁和总经理。制造工厂。

Smits has over 25 years of experience, including working with aseptic products and injectable drugs, alongside critical expertise in facility and equipment qualification, system implementation, and process validation.

Smits拥有超过25年的经验，包括使用无菌产品和注射药物，以及在设施和设备认证，系统实施和过程验证方面的关键专业知识。

“Bouwien is joining us at a critical moment in the startup process for Civica’s first manufacturing facility,” said Jay Benson, Civica’s Chief Manufacturing and Supply Chain Officer. “Her phenomenal leadership skills and experience with the types of products we are preparing to manufacture in Petersburg make her an invaluable addition to our team.

Civica首席制造和供应链官员Jay Benson说：“在Civica第一家制造工厂启动过程的关键时刻，Bouwien正在加入我们。“她在彼得堡准备制造的产品类型方面的非凡领导技能和经验使她成为我们团队的宝贵补充。

She will be a tremendous asset as we move toward our dream of making essential generic medications available and affordable to everyone.”.

当我们走向为每个人提供基本的通用药物并负担得起的梦想时，她将是一项巨大的资产。”。

“I am very excited to be joining the team at Civica,” said Smits. “The Petersburg facility will be transformative for ensuring safe and reliable supplies of medicines for hospital systems and patients and for bringing much needed affordability into the insulin marketplace.”

Smits说：“加入Civica的团队我非常兴奋。”。“彼得堡设施将为确保医院系统和患者的安全可靠的药品供应以及将急需的负担能力带入胰岛素市场进行变革。”

Prior to joining Civica, Smits was Vice President of Quality at Sage Therapeutics. Before that, she was with Takeda, serving as the Site Quality Head, Massachusetts Biologics Operations.

在加入Civica之前，Smits是Sage Therapeutics的质量副总裁。在此之前，她与武田一起，担任马萨诸塞州生物制品业务的现场质量负责人。

About Civica

关于Civica

Civica Inc. (Civica Rx, Civica) is a nonprofit, 501(c)(4) social welfare organization established in 2018 by health systems and philanthropies to increase the reliability of the drug supply chain by reducing drug shortages and related high prices in the United States. An experienced team of healthcare and pharmaceutical industry leaders is at the helm of the organization..

Civica Inc.（Civica Rx，Civica）是一家非营利性的501（c）（4）社会福利组织，于2018年由卫生系统和慈善机构成立，旨在通过减少药物短缺和相关的高价来提高药物供应链的可靠性。美国。一个经验丰富的医疗保健和制药行业领导者团队正在该组织的掌握之中。。

Civica’s mission is to ensure that quality generic medications are accessible and affordable to everyone. Today, more than 55 health systems have joined Civica. They represent more than 1,500 hospitals and one third of all U.S. hospital beds. Most recently, Civica announced its plans to provide affordable medications for consumers in an outpatient setting, including affordable insulin.

Civica的使命是确保每个人都能获得高质量的仿制药。今天，超过55个卫生系统加入了Civica。他们代表1500多家医院和美国所有病床的三分之一。最近，Civica宣布计划在门诊为消费者提供负担得起的药物，包括负担得起的胰岛素。

Civica insulin will be available to people with diabetes at significantly lower prices than insulins currently on the market - no more than $30 per vial and $55 per pack of five pens..

Civica胰岛素将以比目前市场上胰岛素低得多的价格提供给糖尿病患者-每瓶不超过30美元，每包五笔55美元。。

Civica’s nearly completed essential medicines manufacturing facility in Petersburg, Virginia, will produce sterile injectable medications used in hospitals for emergency room and intensive-care unit treatments, surgeries, and to treat other serious conditions. This facility will also manufacture insulin vials and prefilled pens for nationwide distribution..

Civica在弗吉尼亚州彼得堡市近乎完成的基本药物生产设施将生产医院用于急诊室和重症监护病房治疗，手术以及治疗其他严重疾病的无菌注射药物。该设施还将生产胰岛素瓶和预充笔，供全国分销。。